Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease

Author:

Bouquet Jerome1,Soloski Mark J.2,Swei Andrea3,Cheadle Chris2,Federman Scot1,Billaud Jean-Noel4,Rebman Alison W.2,Kabre Beniwende1,Halpert Richard4,Boorgula Meher2,Aucott John N.2,Chiu Charles Y.1ORCID

Affiliation:

1. Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA

2. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

3. Department of Biology, San Francisco State University, San Francisco, California, USA

4. Qiagen Bioinformatics, Redwood City, California, USA

Abstract

ABSTRACT Lyme disease is a tick-borne illness caused by the bacterium Borrelia burgdorferi , and approximately 10 to 20% of patients report persistent symptoms lasting months to years despite appropriate treatment with antibiotics. To gain insights into the molecular basis of acute Lyme disease and the ensuing development of post-treatment symptoms, we conducted a longitudinal transcriptome study of 29 Lyme disease patients (and 13 matched controls) enrolled at the time of diagnosis and followed for up to 6 months. The differential gene expression signature of Lyme disease following the acute phase of infection persisted for at least 3 weeks and had fewer than 44% differentially expressed genes (DEGs) in common with other infectious or noninfectious syndromes. Early Lyme disease prior to antibiotic therapy was characterized by marked upregulation of Toll-like receptor signaling but lack of activation of the inflammatory T-cell apoptotic and B-cell developmental pathways seen in other acute infectious syndromes. Six months after completion of therapy, Lyme disease patients were found to have 31 to 60% of their pathways in common with three different immune-mediated chronic diseases. No differential gene expression signature was observed between Lyme disease patients with resolved illness to those with persistent symptoms at 6 months post-treatment. The identification of a sustained differential gene expression signature in Lyme disease suggests that a panel of selected human host-based biomarkers may address the need for sensitive clinical diagnostics during the “window period” of infection prior to the appearance of a detectable antibody response and may also inform the development of new therapeutic targets. IMPORTANCE Lyme disease is the most common tick-borne infection in the United States, and some patients report lingering symptoms lasting months to years despite antibiotic treatment. To better understand the role of the human host response in acute Lyme disease and the development of post-treatment symptoms, we conducted the first longitudinal gene expression (transcriptome) study of patients enrolled at the time of diagnosis and followed up for up to 6 months after treatment. Importantly, we found that the gene expression signature of early Lyme disease is distinct from that of other acute infectious diseases and persists for at least 3 weeks following infection. This study also uncovered multiple previously undescribed pathways and genes that may be useful in the future as human host biomarkers for diagnosis and that constitute potential targets for the development of new therapies.

Funder

Swartz Foundation

Bay Area Lyme Foundation

Stabler Foundation

Lyme Research Alliance

Lyme Disease Research Foundation, Inc.

Office of Extramural Research, National Institutes of Health

Abbott Laboratories

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Reference53 articles.

1. Lyme borreliosis

2. Lyme Disease Testing by Large Commercial Laboratories in the United States

3. Three sudden cardiac deaths associated with Lyme carditis—United States, November 2012-July 2013;Centers for Disease C, Prevention;MMWR Morb Mortal Wkly Rep,2013

4. Chronic Lyme Disease: A Review

5. Diagnostic challenges of early Lyme disease: Lessons from a community case series

Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3